MX2019010108A - Derivados de azetidina. - Google Patents
Derivados de azetidina.Info
- Publication number
- MX2019010108A MX2019010108A MX2019010108A MX2019010108A MX2019010108A MX 2019010108 A MX2019010108 A MX 2019010108A MX 2019010108 A MX2019010108 A MX 2019010108A MX 2019010108 A MX2019010108 A MX 2019010108A MX 2019010108 A MX2019010108 A MX 2019010108A
- Authority
- MX
- Mexico
- Prior art keywords
- azetidine derivative
- tautomer
- stereoisomer
- drugs
- treat
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F5/00—Compounds containing elements of Groups 3 or 13 of the Periodic Table
- C07F5/02—Boron compounds
- C07F5/025—Boronic and borinic acid compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/69—Boron compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F5/00—Compounds containing elements of Groups 3 or 13 of the Periodic Table
- C07F5/02—Boron compounds
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
En la presente solicitud se describe un compuesto representado por la fórmula (I), o una sal farmacéuticamente aceptable, un tautómero de este, un estereoisómero de este o un isómero geométrico de este, y usos de este en la preparación de fármacos para tratar o prevenir el mieloma múltiple.
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201710112350 | 2017-02-28 | ||
| CN201710805883 | 2017-09-08 | ||
| PCT/CN2018/077583 WO2018157820A1 (zh) | 2017-02-28 | 2018-02-28 | 氮杂环丁烷衍生物 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| MX2019010108A true MX2019010108A (es) | 2020-01-13 |
| MX379576B MX379576B (es) | 2025-03-11 |
Family
ID=63370561
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2019010108A MX379576B (es) | 2017-02-28 | 2018-02-28 | Derivados de azetidina |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US11014943B2 (es) |
| EP (1) | EP3590944B1 (es) |
| JP (1) | JP7083836B2 (es) |
| KR (1) | KR102547709B1 (es) |
| CN (2) | CN110461855B (es) |
| AU (1) | AU2018228555B2 (es) |
| CA (1) | CA3054459A1 (es) |
| ES (1) | ES2928298T3 (es) |
| IL (1) | IL268967B2 (es) |
| MX (1) | MX379576B (es) |
| PH (1) | PH12019550154B1 (es) |
| SG (1) | SG11201907945YA (es) |
| WO (1) | WO2018157820A1 (es) |
| ZA (1) | ZA201905646B (es) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SG11202100907TA (en) * | 2018-08-02 | 2021-03-30 | Chia Tai Tianqing Pharmaceutical Group Co Ltd | Borate of azetidine derivative |
| CN110790780B (zh) * | 2018-08-02 | 2022-12-30 | 正大天晴药业集团股份有限公司 | 含硼的氮杂环丁烷衍生物 |
| CN111039965B (zh) * | 2018-10-12 | 2020-12-01 | 新发药业有限公司 | 一种法硼巴坦的简便制备方法 |
| CN119031933A (zh) * | 2022-04-12 | 2024-11-26 | 正大天晴(广州)医药有限公司 | 蛋白酶体抑制剂与抗pd-1抗体的药物组合 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101120006A (zh) * | 2005-02-11 | 2008-02-06 | 赛福伦公司 | 蛋白酶体抑制剂及其使用方法 |
| US7468383B2 (en) * | 2005-02-11 | 2008-12-23 | Cephalon, Inc. | Proteasome inhibitors and methods of using the same |
| MX350432B (es) | 2012-01-19 | 2017-09-06 | Agios Pharmaceuticals Inc | Compuestos terapeuticamente activos y sus metodos de empleo. |
| WO2016140879A1 (en) | 2015-03-03 | 2016-09-09 | Biohaven Pharmaceutical Holding Company Ltd. | Riluzole prodrugs and their use |
| CN105732683B (zh) * | 2016-03-25 | 2018-10-16 | 南京林业大学 | 一类羧酸与α氨基酸组成的二肽硼酸及其酯类化合物、制备方法及其用途 |
| CN110790780B (zh) | 2018-08-02 | 2022-12-30 | 正大天晴药业集团股份有限公司 | 含硼的氮杂环丁烷衍生物 |
-
2018
- 2018-02-28 CA CA3054459A patent/CA3054459A1/en active Pending
- 2018-02-28 US US16/489,282 patent/US11014943B2/en not_active Expired - Fee Related
- 2018-02-28 AU AU2018228555A patent/AU2018228555B2/en active Active
- 2018-02-28 EP EP18760796.5A patent/EP3590944B1/en active Active
- 2018-02-28 PH PH1/2019/550154A patent/PH12019550154B1/en unknown
- 2018-02-28 CN CN201880017090.1A patent/CN110461855B/zh active Active
- 2018-02-28 MX MX2019010108A patent/MX379576B/es unknown
- 2018-02-28 SG SG11201907945YA patent/SG11201907945YA/en unknown
- 2018-02-28 KR KR1020197028203A patent/KR102547709B1/ko active Active
- 2018-02-28 WO PCT/CN2018/077583 patent/WO2018157820A1/zh unknown
- 2018-02-28 CN CN202110268018.XA patent/CN113061144A/zh active Pending
- 2018-02-28 ES ES18760796T patent/ES2928298T3/es active Active
- 2018-02-28 JP JP2019547081A patent/JP7083836B2/ja active Active
-
2019
- 2019-08-27 ZA ZA2019/05646A patent/ZA201905646B/en unknown
- 2019-08-27 IL IL268967A patent/IL268967B2/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| AU2018228555A1 (en) | 2019-10-10 |
| US11014943B2 (en) | 2021-05-25 |
| PH12019550154A1 (en) | 2020-03-16 |
| JP7083836B2 (ja) | 2022-06-13 |
| MX379576B (es) | 2025-03-11 |
| US20200115392A1 (en) | 2020-04-16 |
| PH12019550154B1 (en) | 2024-06-05 |
| SG11201907945YA (en) | 2019-09-27 |
| BR112019017844A2 (pt) | 2020-04-14 |
| CA3054459A1 (en) | 2018-09-07 |
| CN110461855A (zh) | 2019-11-15 |
| ZA201905646B (en) | 2022-03-30 |
| AU2018228555B2 (en) | 2022-04-07 |
| CN110461855B (zh) | 2021-02-19 |
| IL268967B (en) | 2022-11-01 |
| KR20190125367A (ko) | 2019-11-06 |
| JP2020509020A (ja) | 2020-03-26 |
| KR102547709B1 (ko) | 2023-06-23 |
| ES2928298T3 (es) | 2022-11-16 |
| CN113061144A (zh) | 2021-07-02 |
| WO2018157820A1 (zh) | 2018-09-07 |
| EP3590944A4 (en) | 2020-12-09 |
| EP3590944B1 (en) | 2022-09-14 |
| EP3590944A1 (en) | 2020-01-08 |
| IL268967A (en) | 2019-10-31 |
| IL268967B2 (en) | 2023-03-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CL2019002204A1 (es) | Compuestos inhibidores del vih. | |
| CL2020000886A1 (es) | Derivados de 1-benzil-2-imino-4-fenil-5-oxoimidazolidina como inhibidores de la proteasa del vih. | |
| PH12016502382A1 (en) | Substituted indazole compounds as irak4 inhibitors | |
| MX380394B (es) | Compuesto novedoso de bifenilo o una sal del mismo. | |
| CO2019004034A2 (es) | Compuesto de piridina | |
| MX2022014864A (es) | Compuestos de bisamida que activan el sarcomero y sus usos. | |
| AR103680A1 (es) | Inhibidores selectivos de bace1 | |
| ES2721001T3 (es) | Derivado de isoindolina, y composiciones y métodos para tratar una enfermedad neurodegenerativa | |
| MX2017009449A (es) | Inhibidor jak. | |
| MX2016008665A (es) | Derivado basado en 1,2-naftoquinona y metodo de preparacion del mismo. | |
| CL2019001041A1 (es) | Compuestos terapéuticos y métodos para utilizarlos. | |
| MX2017003780A (es) | Composicion farmaceutica para tratar colitis ulcerativa. | |
| UY36124A (es) | Derivados de carboxamida | |
| MX2019010108A (es) | Derivados de azetidina. | |
| MX394782B (es) | Compuestos para el tratamiento de enfermedades asociadas con una disfunción mitocondrial. | |
| UY36123A (es) | Derivados de carboxamida | |
| MX2020013297A (es) | Compuestos para el tratamiento o la prevencion de enfermedades hepaticas. | |
| MX2020003732A (es) | Derivado de anillo fusionado como inhibidor del receptor a2a. | |
| AR105821A1 (es) | COMPUESTOS ÚTILES PARA INHIBIR ROR-g-T | |
| MX2019008181A (es) | Inhibidores selectivos hdac6, metodos de preparacion y aplicacion de los mismos. | |
| CO2019013254A2 (es) | Compuestos bicíclicos 5,6-fusionados y composiciones para el tratamiento de enfermedades parasitarias | |
| CO2019007836A2 (es) | Derivados de pirrolotriazina como inhibidor de cinasas | |
| CO2018002545A2 (es) | Formulaciones de 3-(5-amino-2-metil-4-oxo-4h-quinazolin-3-il)-piperidin-2,6-diona | |
| MX386902B (es) | Metodos para el tratamiento de trastornos cardiovasculares. | |
| PH12021550248A1 (en) | Borate of azetidine derivative |